Page 5 - நிக்கோலஸ் நிறுவனம் இணைக்கப்பட்டது News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Absci Announces Pricing of Initial Public Offering VANCOUVER, Wash., July 21, 2021 (GLOBE NEWSWIRE) Absci Corporation (“Absci”), the synthetic biology company unlocking the potential of proteins as next-generation therapeutics, today announced the pricing of its initial public offering of 12,500,000 shares of common stock at a public offering price of $16.00 per share. All of the shares of common stock are being offered by Absci. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Absci, are expected to be $200.0 million, excluding any exercise of the underwriters’ option to purchase additional shares. Absci’s common stock is expected to begin trading on the Nasdaq Global Select Market on July 22, 2021, under the ticker symbol “ABSI.” The offering is expected to close on July 26, 2021, subject to the satisfaction of customary closing conditions. In addition, Absci has granted the underwrit

United statesSan franciscoBritish columbiaBroadridge financial solutionsExchange commission onJp morgan securitiesNicolaus company incorporatedCredit suisseCredit suisse securities united statesProspectus departmentAbsci corporationNasdaq global select marketBofa securitiesExchange commissionIsland avenueSuisse securities